Ophthalmic manifestations of Gaucher disease: the most common lysosomal storage disorder

Further Publications

Ocular Manifestations of Behçet's Disease: An Update on Diagnostic Challenges and Disease Management

J Clin Med

Zając H, Turno-Kręcicka A

doi: 10.3390/jcm10215174

Glaucoma and Ocular PressureMacular DiseasesOcular Oncology

Ophthalmic Manifestations of Congenital Zika Syndrome in Colombia and Venezuela

JAMA Ophthalmol.

Yepez JB, Murati FA, Pettito M, Peñaranda CF, de Yepez J, Maestre G, Arevalo JF; Johns Hopkins Zika Center

doi: 10.1001/

Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease

Eur J Ophthalmol.

Nichols KK, Donnenfeld ED, Karpecki PM, Hovanesian JA, Raychaudhuri A, Shojaei A, Zhang S

doi: 10.1177/1120672118791936.

Ocular Motor Manifestations of Multiple Sclerosis

J Neuroophthalmol.

Nerrant E, Tilikete C

doi: 10.1097/WNO.

Dry Eye Disease

Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review

Ocul Surf.

Holland EJ, Darvish M, Nichol KK, Jones L, Karpecki PM

doi: 10.1016/j.jtos.2019.02.012.

Conjunctivitis

A Panel of Broad-Spectrum Antivirals in Topical Ophthalmic Medications from the Drug Repurposing Approach during and after the Coronavirus Disease 2019 Era

J Clin Med.

Napoli PE, Mangoni L, Gentile P, Braghiroli M, Fossarello M

doi: 10.3390/jcm9082441.

Association of Steroid 5α-Reductase Type 3 Congenital Disorder of Glycosylation With Early-Onset Retinal Dystrophy

JAMA Ophthalmol.

Taylor RL, Arno G, Poulter JA, Khan KN, Morarji J, Hull S, Pontikos N, Rueda Martin A, Smith KR, Ali M, Toomes C, McKibbin M, Clayton-Smith J, Grunewald S, Michaelides M, Moore AT, Hardcastle AJ, Inglehearn CF, Webster AR, Black GC; UK Inherited Retinal Disease Consortium and the 100,000 Genomes Project

doi: 10.1001/

Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease

Br J Ophthalmol.

Hong JW, Kang S, Song MK, Ahn CJ, Sa HS

doi: 10.1136/

Further PublicationsDry Eye Disease

Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients With Moderate to Severe Dry Eye Disease: A Post Hoc Analysis of 2 Randomized Clinical Trials

JAMA Ophthalmol

Holland EJ, Jackson MA, Donnenfeld E, Piccolo R, Cohen A, Barabino S, Rolando M, Figueiredo FC

doi: 10.1001/jamaophthalmol.2021.3943

Related content